论文部分内容阅读
为评价地榆升白片与利血联合治疗Graves病伴有粒细胞减少症的效果。将112例Graves病伴有粒细胞减少症患者分为利血生治疗组、地榆升白片治疗组、地榆升白片加利血升治疗组,连续治疗4周,分别观察粒细胞上升水平。结果表明,地榆升白片治疗组粒细胞上升水平明显高于利血生治组(P<0.01),地榆升白片加利血生治疗组粒细胞上升水平分别明显高于利血生治疗组(P<0.01)和地榆升白片治疗组(P<0.01)。地榆升白片与利血生联用可有效提高Graves病伴有粒细胞减少症患者外周血粒细胞水平。
In order to evaluate the effect of treating the patients with Graves’ disease accompanied by granulocytopenia with the combination of Diyu Shenglixi tablet and reserstion of blood. 112 cases of Graves disease associated with neutropenia patients were divided into reserpine group, Burmese rose white tablets treatment group, Burmese rose white tablets Jialing blood rose treatment group, continuous treatment for 4 weeks, were observed granulocytopenia Level. The results showed that the increase of granulocytes in Diyu Shengbai tablet treatment group was significantly higher than that in Shengxueshengji group (P <0.01), and the increase of granulocytes in Diyu Shengbai tablet Treatment group (P <0.01) and Burmese rose tablets treatment group (P <0.01). Burnet rose tablets and reserpine combined can effectively improve the Graves disease associated with neutropenia in patients with peripheral blood neutrophil levels.